MedTrace Logo

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

NCT05799898 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-04-05

No results posted yet for this study

Summary

Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors.

Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors.

Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.

Conditions

  • Cancer
  • Immune Checkpoint Inhibitor
  • Cardiovascular Complication
  • Immune-related Adverse Event

Interventions

OTHER

No intervention for research purposes only

No intervention for research purposes only

Sponsors & Collaborators

  • Institut Mutualiste Montsouris

    lead OTHER

Principal Investigators

  • Mariana Mirabel, MD, PhD · Institut Mutualiste Montsouris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2023-07-01
Completion
2030-01-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05799898 on ClinicalTrials.gov